News
![FDA building](https://pharmaphorum.com/wp-content/uploads/2017/05/FDA-building-image.jpg)
Shionogi's Mulpleta gets FDA green light for patients with l...
The US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic liver disease who are about to undergo a medical procedure.<